Article and Video CATEGORIES
GRACE has partnered with Lilly Oncology for the REThink Testing Campaign
for Lung Cancer Awareness Month
BRIDGING The Biomarker Gaps
More than 1.8 million Americans will face a new cancer diagnosis this year. Each of these cases is unique. Biomarker testing gives you more knowledge and helps empower well-informed treatment decisions. For Lung Cancer Awareness Month, we have partnered with Lilly Oncology to help spread the word and education about biomarker testing, and the important role it plays in ensuring that a patient gets matched to the right treatment at the right time.
Please feel free to offer comments and raise questions in our
Next Previous linkPrevious PostNext Post
Hi Caregiver and welcome to Grace. I'm sorry that you need to be here and hope we can help. Osimertinib has better efficacy than gefitinib (including OS and reaching the brain)...
Hi Bob, Welcome to Grace. I'm sorry about your sil. Unfortunately, cancer becomes resistant to TKIs like tagrisso. Sometimes all of the cancer becomes resistant at once and sometimes just parts...